Obesity — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for obesity. 192 active patents protecting 2 drugs from 2+ originators. First major cliff: 2026. Daily refresh.

2
Approved drugs
192
Active US patents
48/100
Avg vulnerability
$27.6B
Annual revenue covered

Originators in Obesity

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Novo Nordisk 178 patents Azurity 14 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating obesity. Each bar = one year. Y-axis scaled to peak year (42 patents).

20
26
8
27
42
31
4
32
21
33
26
34
23
37
23
38
14
39
5
40
6
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Ozempic
semaglutide
 Novo Nordisk 178 44 $27.4B 2026-07-17
Amphetamine Sulfate
AMPHETAMINE SULFATE
 Azurity 14 51 $172M 2037-03-10

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
11896562 Amphetamine Sulfate method of use 75 2037-03-10
8129343 Ozempic method of use 64 2031-12-05
8129343 Ozempic method of use 64 2031-12-05
8129343 Ozempic method of use 64 2031-12-05
9278123 Ozempic method of use 64 2031-12-16
9278123 Ozempic method of use 64 2031-12-16
9278123 Ozempic method of use 64 2031-12-16

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
8129343 Ozempic composition of matter 0 2031-12-05
8129343 Ozempic composition of matter 0 2031-12-05
8129343 Ozempic composition of matter 0 2031-12-05
8129343 Ozempic composition of matter 0 2031-12-05
8129343 Ozempic composition of matter 0 2031-12-05
11382957 Ozempic composition of matter 6 2031-12-16
11382957 Ozempic composition of matter 6 2031-12-16
11382957 Ozempic composition of matter 6 2031-12-16
8129343 Ozempic composition of matter 6 2031-12-05
8129343 Ozempic composition of matter 6 2031-12-05

Related